HPV Vaccine for Increasing Vaccination Rates
(HPV Trial)

Recruiting in Palo Alto (17 mi)

Overseen byJulie HT Dang, PhD

Age: < 18

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of California, Davis

No Placebo Group

Trial Summary

What is the purpose of this trial?Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.

Eligibility Criteria

This trial is for eligible patients aged 10-12 within the UC Davis Health Community Physician primary care practices, aiming to increase HPV vaccine uptake. Specific inclusion and exclusion criteria details are not provided.

Inclusion Criteria

I am between 10-12 years old and eligible for the HPV vaccine.

Exclusion Criteria

I have received the HPV vaccine.

I cannot receive the HPV vaccine due to health reasons.

Participant Groups

The study is testing a culturally tailored intervention designed to boost HPV vaccination rates among young patients. It's set up as a randomized controlled trial, meaning participants will be randomly assigned to receive this new approach or continue with standard practices.

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention ArmExperimental Treatment1 Intervention

These clinics will receive the multilevel intervention which will include tailored parent/patient education, appointment scheduling assistance, and primary care team trainings.

Group II: Control ArmActive Control1 Intervention

These clinics will not receive any intervention and will continue with care as usual.